Light-Activated Molecular Switch Shows Promise Against Dormant Cancer Cells

Scientists at ETH Zurich have developed a novel light-controlled molecular switch designed to target and destroy specific receptors that allow cancer cells to enter a dormant state, thereby evading conventional treatments. This innovative discovery could pave the way for new therapeutic strategies, particularly for aggressive cancers that are currently difficult to treat. The research offers a hopeful direction for improving cancer patient outcomes.